Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 2.065% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) CC1(OC(=O)C2CCCC2)C(=O)C=C2C=C(c3ccsc3)N(C3CCCC3)C=C2C1=O
b.) CCN(CC)C(=O)COc1ccc(S(=O)(=O)N2CCCC2)cc1
c.) Cn1nccc1C(=O)Nc1nnc(C2CC2)s1
d.) COc1ccccc1NC(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1
Answer: c. Cn1nccc1C(=O)Nc1nnc(C2CC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nccc1C(=O)Nc1nnc(C2CC2)s1
Cn1nccc1C(=O)Nc1nnc(C2CC2)s1
N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-2-methylpyrazole-3-carboxamide